DR
DRUG.AU Betashares Global Healthcare Currency Hedged ETF
- AUD
No recent price
- Total assets
- 185M
- Expense ratio
- -
- Dividend yield
- 3.75%
- 1-year return
- +23.90%
- Holdings
- 10
- Since
- 2016
Fund data as reported by the issuer, updated Oct 31, 2026. Total assets are in the fund's base currency.
What does DRUG.AU invest in?
- Mostly Stock (100.0%)
- Largest sector: Healthcare (100.0%)
- Largest region: United States (70.4%)
- Top 3 holdings: 22.8% of the fund
Asset allocation
- Stock 100.0%
Top holdings
- Johnson & Johnson 8.10%
- Eli Lilly and Company 7.97%
- AbbVie Inc 6.68%
- Merck & Company Inc 5.53%
- UnitedHealth Group Incorporated 5.09%
Betashares Global Healthcare Currency Hedged ETF performance
Sharpe ratio 0.24- This year
- +15.33%
- 1 year
- +23.90%
- 3 years
- +12.36%
- 5 years
- +6.36%
Volatility 15.7% over 1 year and 16.5% over 3 years. Moderate, similar to a broad stock index.
Total returns in the fund's currency as reported by the issuer; past returns do not predict future returns. Volatility is the yearly standard deviation of returns. Ask AI to explain these numbers
DRUG.AU price
Prices on the chart can differ slightly from the closing prices StockSummer shows.
Betashares Global Healthcare Currency Hedged ETF top holdings
52.2% of the fund| Holding | Sector | Country | Weight |
|---|---|---|---|
| Johnson & Johnson JNJ.US | Healthcare | United States | 8.10% |
| Eli Lilly and Company LLY.US | Healthcare | United States | 7.97% |
| AbbVie Inc ABBV.US | Healthcare | United States | 6.68% |
| Merck & Company Inc MRK.US | Healthcare | United States | 5.53% |
| UnitedHealth Group Incorporated UNH.US | Healthcare | United States | 5.09% |
| AstraZeneca PLC AZN.LSE | Healthcare | United Kingdom | 4.05% |
| Thermo Fisher Scientific Inc TMO.US | Healthcare | United States | 3.97% |
| Novartis AG NOVN.SW | Healthcare | Switzerland | 3.91% |
| Roche Holding AG ROP.SW | Healthcare | Switzerland | 3.77% |
| Amgen Inc AMGN.US | Healthcare | United States | 3.11% |
DRUG.AU sector exposure
- Healthcare100.0%
Share of the stocks in the fund.
DRUG.AU regional exposure
- United States70.4%
- Europe - except Euro13.0%
- Eurozone6.9%
- Japan6.1%
- United Kingdom5.4%
- Asia - Developed0.4%
Share of the stocks in the fund.
Company size
Average market cap 277B- Mega cap27.0%
- Big cap56.1%
- Medium cap14.9%
- Small cap0.1%
Betashares Global Healthcare Currency Hedged ETF fund profile
- Fund name
- Betashares Global Healthcare Currency Hedged ETF
- Ticker
- DRUG.AU
- Exchange
- Australian Securities Exchange
- Issuer
- BetaShares Capital Ltd
- Index tracked
- -
- Category
- Global Equity
- Domicile
- Australia
- Inception date
- Aug 4, 2016
- Trading currency
- AUD
- Expense ratio
- -
- Dividends paid
- Half-yearly
- Annual turnover
- 0.1%